Previous Page Next Page

CARDIOVASCULAR DISEASE (also see Women’s Health)


Acute Coronary Syndrome: One-Year Total Costs and Clinical Outcomes in the Kaiser Permanente Medical Care Program, Northern California Region

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding:
Eli Lilly
Title describes study.


Acute Outcomes & Management of TIA with Carotid Disease

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding
: National Institute of Neurological Disorders and Stroke/NIH/DHHS


A Nested Case-Control Study of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) and Subclinical Cardiovascular Disease Among Young Adults

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of
Funding: GlaxoSmithKline Company
Description:
This study describes the distribution of Lp-LA2 in young adults, its correlation with traditional and new risk factors and its association with coronary artery calcification.


A Prospective Study of Predictors of Heart Failure in a Large Population

Division of Research Adjunct Principal Investigator: Arthur Klatsky, MD
Primary Source of
Funding: Kaiser Permanente Community Benefit Programs
Description
: This study examines a defined cohort of predictors, survival, and extent of hospitalization among 2700 persons with heart failure diagnosed from 1978-2000.


Androgens and Subclinical Atherosclerosis in Young Women

Division of Research Site Principal Investigator: Barbara Sternfeld, PhD
Primary Source of Funding:
National Health, Lung, and Blood Institute
Description
: This study examines cross-sectional and longitudinal relations of androgens and ovarian findings with cardiovascular disease risk factors and subclinical disease.


Angiography in Angina (ANGINA) Study: Cardiac Procedure Use and Outcomes in New Onset Angina

Division of Research Principal Investigator: Alan S. Go, MD
Primary Source of Funding:
The Permanente Medical Group
Title describes study.


Asymmetric Dimethyl-Arginine, Coronary Risk Factors and Subclinical Disease in Young Adults

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of Funding:
American Heart Association
Description:
This study examines the distribution of a novel risk marker of endothelial function, asymmetric dimethyl-arginine, and its relation to coronary risk factors and subclinical coronary artery disease among young adults enrolled in the Coronary Heart Disease Risk Factors in Young Adults.


Body Size, Cardiovascular Risk Factors, and Health Outcomes in the California Men's Health Study

Division of Research Principal Investigator: Bette Caan, DrPH
Primary Source of Funding:
Sanofi-Aventis Group (aka Sanofi-Synthelabo, Inc)
Description:
The goal of this study is to prospectively examine in a large cohort of men how the combination of weight (BMI) and known clinical/behavioral risk factors (hypertension, smoking, dyslipidemia, impaired glucose tolerance, diet, alcohol, physical activity) impact the following endpoints: cardiovascular disease, diabetes, hypertension, depression, musculoskeletal conditions, health care utilization, and health care costs.


Cardiac and Renal Disease Study (CARDS)

Division of Research Principal Investigator: Carlos Iribarren, MD, MPH, PhD
Primary Source of
Funding: National Heart, Lung, and Blood Institute
Description:
The study evaluates whether baseline and decline in renal function over time are independent predictors of coronary heart disease, stroke, heart failure, and peripheral vascular disease.


Congestive Heart Failure and Pioglitazone Use

Division of Research Principal Investigator: Andrew J. Karter, PhD
Primary Source of
Funding: American Diabetes Association
Description:
This study assesses whether the diabetes treatment pioglitazone or other diabetes therapies (sulfonylurea, metformin, or insulin use) are associated with an increased risk of congestive heart failure.


Clinical and Genetic Predictors of Myocardial Infarction in Coronary

Division of Research Principal Investigator: Alan S. Go, MD
Primary Source of
Funding: Reynolds Foundation
Description:
This study examines the pathophysiology of coronary disease based on genetics and nongenetic risk markers, with the long-term goal of using these genetic risk factors or risk modifiers to improve diagnosis and risk stratification.


Does A Random Serum Endostatin Level Predict the Subsequent Risk of Cancer or Myocardial Infarction?

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of
Funding: Kaiser Foundation Research Institute
Description:
This study examines whether a baseline endostatin level is a risk factor for the development of cancer and ischemic heart disease.


Epidemiology and Outcomes of Anemia Complicating Chronic Heart Failure Within a Large Health Maintenance Organization

Division of Research Principal Investigator: Alan S. Go, MD
Primary Source of
Funding: Amgen, Inc.
Description
: This study examines the independent role of renal insufficiency and anemia on the care and outcomes of chronic heart failure within a large cohort of both hospitalized and ambulatory adults.


Epidemiology of Anticoagulation in Atrial Fibrillation (The Anticoagulation and Risk Factors In Atrial Fibrillation, ATRIA, Study)

Division of Research Site Principal Investigator: Alan S. Go, MD
Primary Source of Funding:
National Heart Lung and Blood Institute
Description:
This longitudinal cohort study evaluates the epidemiology of nonvalvular atrial fibrillation in ambulatory patients, including assessing warfarin use for stroke prevention; determining rates of stroke and major bleeding events, and ascertaining the clinical and genetic risk factors for ischemic stroke in the setting of atrial fibrillation.


Epidemiology, Management Outcomes and Cost of Heart Failure in Managed Care

Division of Research Principal Investigator: Alan S. Go, MD
Primary Source of Funding
: G.D. Searle
Description:
This cohort study of patients hospitalized with heart failure assesses the changing epidemiology, medical and surgical therapies, variation in treatment and clinical outcomes, and identification of modifiable barriers to optimal heart failure care.


Epidemiology: Oxidative Stress and Early Atherosclerosis

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding
: National Heart, Lung, and Blood Institute/NIH/DHHS
Description:
As a sub-contractor to Univ. of Minnesota, we will obtain blood and urine specimens at the CARDIA examination for shipment to Dr. Myron Gross’s laboratory for study related analyses.


Epidemiology, Practice Outcomes, and Cost of Heart Failure in Managed Care (The EPOCH Study)

Division of Research Principal Investigator: Alan S. Go, MD
Primary Source of Funding:
G.D. Searle and Company, Inc.
Description:
This cohort study of patients hospitalized with heart failure assesses the changing epidemiology, medical and surgical therapies, variation in treatment and clinical outcomes, and identification of modifiable barriers to optimal heart failure care.


Function, Living, Outcomes & Work in COPD (FLOW)

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of Funding
: National heart Lung, and Blood Institute/NIH/DHHS
Description:
The major goals of the study are: 1) to elucidate the factors that determine the risk of developing disability and poor health outcomes among adults with COPD, controlling for degree of pulmonary function impairment; 2) to evaluate the impact of specific functional limitations on the risk of developing disability in daily activities and work among relatively young adults with COPD; 3) also to elucidate the impact of disability on future adverse health outcomes.


Integrative Study of Brain Vascular Malformations

Division of Research Site Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding:
National Institute of Neurological Disorders and Stroke
Description:
This study tests the association of potential genetic risk factors with intracranial hemorrhage occurring after the diagnosis of brain arteriovenous malformation in Kaiser Permanente patients.


Inflammation Genomics and Atherosclerosis Project (IGAP)

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of Funding:
National Institute of Health
Description
: Examine the associations of common variation in inflammation/thrombosis genes with intermediate quantitative phenotypes and sub-clinical coronary atherosclerosis in the Coronary Artery Risk Factor Development in Young Adult (CARDIS) Study, a large, bi-racial cohort study.


Longitudinal Study of Coronary Heart Disease Risk Factors in Young Adults
(CARDIA)

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding:
National Heart, Lung, and Blood Institute
Description:
This study describes the distribution of coronary heart disease risk factors in a biracial cohort of men and women, and identifies habits, behaviors, and life-styles that are associated with initial levels of risk factors and with the evolution of risk factors.


Morbidity and Mortality Due to Cardiovascular Disease Among Patients With Chronic Obstructive Pulmonary Disease (COPD)

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding:
Pfizer, Inc.
Description:
This observational study utilizes hospitalization, outpatient, and pharmacy data to determine the incidence of cardiovascular morbidity and mortality patients with COPD.


Prediction Rules for Stroke after Transient Ischemic Attack

Adjunct Principal Investigator: S. Claiborne Johnston, MD, MPH, PhD
Primary Source of
Funding: American Heart Association
Description:
This project aims to produce simple, validated prediction rules for stroke risk after transient ischemic attack.


Predictors of Spontaneous Cerebral AVM Hemorrhage (Comp.Contin.of 9813)

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of Funding:
National Institute of Neurological Disorders and Stroke/NIH/DHHS
Description:
Determine the trends in the incidence of arteriovenous malformations (AVMs) of the brain and the rate of rebleeding from AVMs.


Primary Stroke Prevention in Childhood Sickle Cell Disease

Division of Research Principal Investigator: Steve Sidney, MD
Primary Source of Funding:
Thrasher Research Fund
Description:
A retrospective study of children with sickle cell disease (SCD) in the Kaiser Permanente Medical Care Program to determine whether to have rates of utilization of transcranial Doppler screening and transfusion therapy have increased, with a subsequent decline in stroke rates, among children with SCD, and whether this screening is cost-effective.


Secondary Prevention After Isochemic Stroke: A Trial of an Evidence-Based System-Wide Intervention

Division of Research Site Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of
Funding: Centers for Disease Control and Prevention
Description:
This study seeks to determine whether a multimodal secondary prevention intervention is effective at increasing utilization of evidence-based treatment in patients with ischemic stroke.


The Abdominal Sagittal Diameter: Long-Term Cardiovascular Outcomes Across the Adult Age Spectrum and Ethnic Groups

Division of Research Principal Investigator: Carlos Iribarren, MD, PhD, MPH
Primary Source of Funding:
Kaiser Foundation Research Institute
Description:
To understand the long-term risks and the population attributable risk percent of cardiovascular outcomes associated with central (abdominal) obesity at different BMI levels.


Twenty Year Changes in Fitness and Cardiovascular Disease Risk

Division of Research Principal Investigator: Stephen Sidney, MD, MPH
Primary Source of
Funding: National Heart, Lung, and Blood Institute
Description:
This Coronary Heart Disease Risk Factors in Young Adults ancillary study seeks to understand the complex, longitudinal relations between physical fitness, physical activity, body mass and composition and fat distribution, and genetic factors and their independent or interactive effects on the development of obesity, the metabolic syndrome, and sub-clinical CVD.

Previous Page Next Page


DOR Administrative Offices
2000 Broadway
Oakland, CA 94612


DOR Clinics
3505 Broadway
Oakland, CA 94611
(510) 891 - 3400
 
Investigator Directory | Publications
Home | About DOR | Studies | Staff
Resources | Jobs | Links | Contacts
Directions | Sitemap

Email your comments and suggestions about this Web site to Division of Research Webmaster
We recommend that you use Microsoft Internet Explorer 4.0 or higher or Netscape Navigator 6.0 or higher.
Copyright 2002 Divison of Research - Kaiser Permanente